Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,667 | 51,039 | 83,155 | 69,246 | 154,758 |
| Marketable Securities | 273,961 | 333,821 | 365,542 | 396,259 | 337,204 |
| TOTAL | $457,124 | $395,364 | $459,115 | $473,454 | $502,101 |
| Non-Current Assets | |||||
| PPE Net | 92,080 | 95,931 | 99,478 | 102,826 | 106,386 |
| Investments And Advances | 1,134 | 15,121 | 3,645 | 37,535 | 62,496 |
| Other Non-Current Assets | 96,545 | 79,934 | 80,599 | 98,511 | 99,988 |
| TOTAL | $189,759 | $190,986 | $183,722 | $238,872 | $268,870 |
| Total Assets | $646,883 | $586,350 | $642,837 | $712,326 | $770,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,936 | 5,779 | 5,897 | 6,205 | 10,229 |
| Accrued Expenses | 24,369 | 25,029 | 31,182 | 31,195 | 44,263 |
| TOTAL | $37,305 | $30,894 | $37,079 | $37,636 | $54,721 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 86 | N/A | 236 | 229 |
| Other Non-Current Liabilities | 94,540 | 94,089 | 93,525 | 91,588 | 93,344 |
| TOTAL | $94,540 | $94,089 | $93,525 | $91,588 | $93,344 |
| Total Liabilities | $131,845 | $124,983 | $130,604 | $129,224 | $148,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 209,112 | 170,853 | 169,092 | 168,277 | 167,626 |
| Common Shares | 209 | 170 | 169 | 168 | 167 |
| Retained earnings | -1,693,591 | -1,627,233 | -1,562,233 | -1,473,988 | -1,412,673 |
| Other shareholders' equity | -780 | -927 | -955 | -2,411 | -3,851 |
| TOTAL | $515,038 | $461,367 | $512,233 | $583,102 | $622,906 |
| Total Liabilities And Equity | $646,883 | $586,350 | $642,837 | $712,326 | $770,971 |